surgical robots market is experiencing rapid global growth, driven by advancements in robotic systems and rising demand for minimally invasive surgeries. These robots help surgeons perform with accuracy, reduce patient recovery time, and minimize complications. The surgical robots market is rapidly expanding as healthcare systems increasingly adopt advanced technologies to improve surgical precision, patient outcomes, and recovery times. Robotic-assisted surgeries offer benefits such as smaller incisions, reduced blood loss, shorter hospital stays, and quicker patient recovery compared to traditional open surgeries.
According to Fortune Business Insights, the surgical robots market was valued at USD 1,463.0 million in 2018 and is projected to reach USD 22,381.6 million by 2032, exhibiting a CAGR of 21.5% during the forecast period (2018-2032). In 2018, North America dominated the surgical robots market with a market share of 71.46%.
In May 2018, Intuitive Surgical secured U.S. FDA clearance for its da Vinci X Surgical System, marking a significant milestone. This advanced robotic platform enables single-port urologic procedures—ushering in a new era of minimally invasive surgery